We are currently all facing a time that we have never experienced before as individuals or as businesses; and are creating and adapting to new ways of living and working.
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected countries in the Middle East, Africa, and Ukraine.
H.H. Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai and Minister of Finance of the United Arab Emirates, received Acino’s CEO Steffen Saltofte at the Zabeel palace in Dubai to review prospects for enhancing cooperation between Acino and the UAE.
Acino's manufacturing plant in Ukraine—Pharma Start—has successfully been certified according to the Good Manufacturing Practice of the European Union (EU GMP).
Acino is delighted to announce that it will begin commercial operations in Turkey.
Acino is proud to have been recognized as the Best Pharmaceutical Company 2019 by the Armenia - Artsakh - Diaspora association in Armenia for our contribution to the development of the country’s pharmaceutical industry, our high-quality medicines and successful cooperation with the Armenian healthcare community.
The partnership will see both companies provide respective services in the creation of high-quality pharmaceutical products.
Partnering with the Iraqi Hypertension Society (IHS), we support our commity in Iraq on World Heart Day.
Acino is proud to announce a partnership with the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences.